The Food and Drug Administration on Thursday announced approval for Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma.
The philanthropic division of supermarket chain Stater Bros. has raised more than a quarter-million dollars for blood cancers.
More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.
Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.
The Food and Drug Administration has approved a new biotech drug for treating two types of lymphoma, the agency said Friday.
In the first study of vitamin K and non-Hodgkin's lymphoma risk, researchers at the Mayo...
A Food and Drug Administration advisory committee declined to recommend approval for a cancer drug...